Safety of quadrivalent meningococcal conjugate vaccine in infants and toddlers 2 to 23-months old.

CONCLUSIONS: Data from this descriptive observational study do not suggest safety concerns associated with MenACWY-CRM when used as part of clinical care of 2-23 month-old infants/toddlers indicated for vaccination. PMID: 31648912 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31648912?dopt=Abstract

Source: Vaccine - October 20, 2019 Category: Allergy & Immunology Authors: Becerra-Culqui TA, Sy LS, Ackerson BK, Slezak JM, Luo Y, Fischetti CA, Ohadike YU, Curina C, Pellegrini M, Solano Z, Tartof SY, Tseng HF Tags: Vaccine Source Type: research